Details for Patent: 12,295,988
✉ Email this page to a colleague
Which drugs does patent 12,295,988 protect, and when does it expire?
Patent 12,295,988 protects OZEMPIC and is included in one NDA.
This patent has thirty-two patent family members in eighteen countries.
Summary for Patent: 12,295,988
| Title: | Semaglutide in medical therapy |
| Abstract: | The present invention relates to semaglutide for use in weight management. |
| Inventor(s): | Lars Holm Damgaard, Soeren Oestergaard Hardt-Lindberg, Thomas Hansen |
| Assignee: | Novo Nordisk AS |
| Application Number: | US18/820,792 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,295,988 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 12,295,988
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | OZEMPIC | semaglutide | SOLUTION;SUBCUTANEOUS | 209637-007 | May 5, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF TREATING TYPE 2 DIABETES | ⤷ Start Trial | ||||
| Novo | OZEMPIC | semaglutide | SOLUTION;SUBCUTANEOUS | 209637-004 | Oct 6, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF TREATING TYPE 2 DIABETES | ⤷ Start Trial | ||||
| Novo | OZEMPIC | semaglutide | SOLUTION;SUBCUTANEOUS | 209637-002 | Apr 9, 2019 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF TREATING TYPE 2 DIABETES | ⤷ Start Trial | ||||
| Novo | OZEMPIC | semaglutide | SOLUTION;SUBCUTANEOUS | 209637-003 | Mar 28, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF TREATING TYPE 2 DIABETES MELLITUS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,295,988
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018348929 | ⤷ Start Trial | |||
| Australia | 2025203535 | ⤷ Start Trial | |||
| Brazil | 112020006246 | ⤷ Start Trial | |||
| Canada | 3078652 | ⤷ Start Trial | |||
| Chile | 2020000812 | ⤷ Start Trial | |||
| China | 111212657 | ⤷ Start Trial | |||
| China | 119838000 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
